Develops collagen products for medical aesthetics and 3D bioprinting.
Dec 2025Revenue $2.37M/yrExpenses $13.9M/yr
No trendCash runway ≈ 7 months from Dec 2025
Figures by year
When will CollPlant Biotechnologies be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $2.37M and expenses $13.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.37M | $13.9M | −$11.5M |
| Dec 2024 | $515K | $17.8M | −$17.3M |
| Dec 2023 | $11.0M | $18.5M | −$7.51M |
| Dec 2022 | $299K | $17.4M | −$17.1M |
| Dec 2021 | $15.6M | $15.6M | $65.0K |
| Dec 2020 | $6.14M | $11.7M | −$5.60M |
| Dec 2019 | $2.32M | $9.95M | −$7.63M |
| Dec 2018 | $5.01M | $9.26M | −$4.25M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.